天新药业
(603235)
| 流通市值：41.94亿 | | | 总市值：124.85亿 |
| 流通股本：1.47亿 | | | 总股本：4.38亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,624,850,171.78 | 1,078,329,053.57 | 1,624,868,496.05 | 1,961,137,890.65 |
| 应收票据及应收账款 | 398,123,815.63 | 404,718,517.45 | 313,814,615.58 | 336,308,529.81 |
| 其中：应收票据 | 113,783,352.84 | 115,958,672.29 | 89,189,854.77 | 58,683,356.41 |
| 应收账款 | 284,340,462.79 | 288,759,845.16 | 224,624,760.81 | 277,625,173.4 |
| 应收款项融资 | 11,741,063.73 | 9,561,696.91 | 54,874,253.04 | 12,962,264.32 |
| 预付款项 | 32,397,202.62 | 19,311,356.02 | 47,500,415.92 | 27,141,951.21 |
| 其他应收款合计 | 3,437,480.57 | 1,398,596.42 | 2,074,833.93 | 2,062,131.88 |
| 存货 | 598,817,047.67 | 589,229,646.47 | 494,189,096.29 | 475,288,977.83 |
| 其他流动资产 | 98,494,220.37 | 111,143,807.64 | 50,436,460.4 | 38,202,841.58 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,777,863,951.65 | 2,695,380,695.48 | 2,707,758,171.21 | 2,853,104,587.28 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | 25,145.26 | 25,145.26 |
| 固定资产 | 1,441,836,826.18 | 1,462,785,203.09 | 1,214,407,845.09 | 1,196,626,984.89 |
| 在建工程 | 1,269,555,876.91 | 1,117,376,914.48 | 960,286,756.38 | 638,541,857.7 |
| 使用权资产 | 3,975,878.51 | 4,701,578.53 | 5,427,278.57 | 6,152,978.59 |
| 无形资产 | 187,075,756.06 | 188,155,921.95 | 189,566,351.02 | 190,426,444.96 |
| 长期待摊费用 | 9,260,895.23 | 9,607,354.49 | 9,953,813.75 | 10,300,273.01 |
| 递延所得税资产 | 81,826,967.47 | 83,175,890.75 | 78,991,373.78 | 80,960,191.94 |
| 其他非流动资产 | 43,450,981.33 | 42,107,570.86 | 105,951,364.9 | 126,506,685.2 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,036,983,181.69 | 2,907,910,434.15 | 2,564,609,928.75 | 2,249,540,561.55 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,814,847,133.34 | 5,603,291,129.63 | 5,272,368,099.96 | 5,102,645,148.83 |
| 流动负债: | | | | |
| 短期借款 | 15,054,858.73 | 16,055,592.06 | 1,000,666.67 | 20,013,333.33 |
| 应付票据及应付账款 | 255,890,009.62 | 250,127,562.32 | 166,510,248.17 | 129,708,878.15 |
| 其中：应付票据 | - | - | - | 13,150,000 |
| 应付账款 | 255,890,009.62 | 250,127,562.32 | 166,510,248.17 | 116,558,878.15 |
| 合同负债 | 16,458,150.61 | 24,022,890.07 | 21,048,141.89 | 19,874,071.54 |
| 应付职工薪酬 | 41,020,387.86 | 109,266,664.54 | 77,895,628.12 | 57,889,037.97 |
| 应交税费 | 36,182,622.46 | 27,687,703.41 | 23,590,021.83 | 54,165,128.08 |
| 其他应付款合计 | 11,468,767.59 | 13,558,275.44 | 6,019,733.09 | 6,893,166.78 |
| 一年内到期的非流动负债 | 13,026,395.16 | 13,380,953.48 | 2,902,800.12 | 2,902,800.11 |
| 其他流动负债 | 37,136,605.26 | 55,684,701.31 | 47,251,505.09 | 41,805,596.56 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 426,237,797.29 | 509,784,342.63 | 346,218,744.98 | 333,252,012.52 |
| 非流动负债: | | | | |
| 长期借款 | 200,948,615.28 | 117,432,594.11 | 100,033,981.82 | 65,228,227 |
| 租赁负债 | 1,463,120.04 | 1,818,190.19 | 2,994,028.39 | 3,779,269.59 |
| 递延收益 | 349,260,516.08 | 358,370,025.56 | 366,459,535.04 | 372,569,044.52 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 551,672,251.4 | 477,620,809.86 | 469,487,545.25 | 441,576,541.11 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 977,910,048.69 | 987,405,152.49 | 815,706,290.23 | 774,828,553.63 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 437,780,000 | 437,780,000 | 437,780,000 | 437,780,000 |
| 资本公积 | 1,999,321,360.82 | 1,996,837,355.05 | 1,994,353,349.28 | 1,991,869,343.51 |
| 减:库存股 | 60,014,480.99 | 60,014,480.99 | 60,014,480.99 | 37,061,173.22 |
| 盈余公积 | 218,890,000 | 218,890,000 | 218,890,000 | 218,890,000 |
| 未分配利润 | 2,240,960,204.82 | 2,022,393,103.08 | 1,865,652,941.44 | 1,716,338,424.91 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,836,937,084.65 | 4,615,885,977.14 | 4,456,661,809.73 | 4,327,816,595.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,836,937,084.65 | 4,615,885,977.14 | 4,456,661,809.73 | 4,327,816,595.2 |
| 负债和股东权益合计 | 5,814,847,133.34 | 5,603,291,129.63 | 5,272,368,099.96 | 5,102,645,148.83 |
| 公告日期 | 2025-04-30 | 2025-04-26 | 2024-10-30 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |